Sep 21, 2025

Featuring an interview with Dr Jonathan Strosberg, including the following topics:

• Overview of extrapulmonary neuroendocrine carcinoma (NEC) (0:00)
• Treatment strategies for extrapulmonary NEC (10:26)
• Targeting DLL3 in extrapulmonary NEC (18:49)
• Early clinical data with obrixtamig for extrapulmonary...

Sep 19, 2025

Featuring a slide presentation and related discussion from Dr Jonathan Strosberg, including the following topics:

• Overview of the classification, grading and incidence of neuroendocrine carcinoma (NEC) (0:00)
• Overview of mutational profile, biomarker assessments and prognosis of NEC (3:45)
• Current treatment paradigm...

Sep 16, 2025

Featuring an interview with Dr Neel Pasricha, including the following topics:

• Anatomy and physiology of the cornea; intersection of ophthalmology and oncology for patients receiving antibody-drug conjugates (ADCs) (0:00)
• Association of corneal toxicities with ADCs (4:56)
• Dose and schedule modifications to mitigate ocular...

Sep 15, 2025

Featuring perspectives from Prof Rebecca A Dent, Dr Hans Lee, Dr Neel Pasricha and Dr Tiffany A Richards, including the following topics: 

• Introduction: The Patient Experience (0:00)
• Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies — Dr Pasricha (10:28)
• Ocular Toxicities...

Apr 26, 2025

Featuring perspectives from Ms Marianne J Davies, Dr Edward B Garon, Ms Marissa Marti-Smith and Dr Tiffany A Traina, including the following topics:

• Introduction (0:00)
• Overview of Antibody-Drug Conjugates (ADCs) (4:40)
• Trastuzumab Deruxtecan (T-DXd) in Patients with HER2-Positive Metastatic Breast Cancer (mBC) with...